Director, Corporate Counsel, Early Research & Development

Who We Are

Bio Marin is a leading rare disease biotechnology company focused on genetically defined conditions.

Guided by our purpose to develop medicines that make a profound impact on people's lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options.

More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.

Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of Bio Marin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.

It takes a village, and at Bio Marin, our general and admin teams are the village behind our success. From the IT experts who manage our technology to the human resources professionals who hire the people who make it all possible, these teams support our organization and span all areas of operations.

Bio Marin is seeking an experienced and business-oriented attorney to serve as the lead legal support and strategic advisor for its Early Research & Development (RED) organization. This role will partner closely with scientific, business, and functional leaders to enable innovative research collaborations, advance Bio Marin's pipeline, and support the company's long-term strategic objectives.

The Director, Corporate Counsel, Early Research & Development will provide proactive legal counsel on a broad range of research, innovation, intellectual property, and transactional matters. The successful candidate will possess deep experience negotiating and drafting complex research and collaboration agreements including licenses, strong intellectual property acumen, and a demonstrated ability to effectively partner with scientists and senior business leaders in a fast-paced life sciences environment.

• Serve as the primary legal advisor to Bio Marin's Early Research & Development organization.
• Provide practical, risk-based legal counsel to scientific and business stakeholders to support research initiatives, external innovation activities, and strategic collaborations.
• Partner closely with senior leaders across Worldwide Research & Development (WWRD), Business Development, Intellectual Property, Alliance Management, Procurement, and other functions.
• Develop trusted relationships with executive and senior leadership and contribute to strategic decision-making.

• Lead the drafting, review, negotiation, and execution of a wide variety of agreements supporting research and development activities, including:
• Confidential Disclosure/Non-Disclosure Agreements (CDAs/NDAs)
• Master Services Agreements (MSAs)
• Material Transfer Agreements (MTAs)
• Sponsored Research Agreements (SRAs)
• Research Collaboration Agreements
• Option, License, and Technology Evaluation Agreements
• Academic and Institutional Collaborations
• Consulting and Scientific Advisory Agreements
• Other strategic research and development transactions
• Structure and negotiate complex licensing, research, and collaboration arrangements involving proprietary technologies, intellectual property rights, and scientific data.
• Advise stakeholders on contractual risk allocation, governance structures, publication rights, ownership of intellectual property, data rights, and commercialization considerations.

• Partner with Bio Marin's Intellectual Property team to support patent strategy and technology transactions.
• Provide strategic legal guidance to business stakeholders regarding intellectual…